Clinical Trial

Resistance Exercise in Patients With Ocular Melanoma

Study acronym: IHOPE
Recruiting
View on ClinicalTrials.gov →
Summary
Choroidal melanoma (CM) is one of the most common intraocular cancers worldwide. During treatment with episcleral brachytherapy, patients require a week of hospitalization in isolation. The primary aim of this study will be to investigate the effects of resistance training during hospitalization on health-related blood biomarkers in CM patients. Our secondary aim will be to assess changes in physical function tests, quality of life and anxiety and depression. Candidates for this study will be patients undergoing CM treatment at the "Hospital Universitari i Politècnic La Fe" of Valencia.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-05-08.
Trial Details
NCT Number NCT06970236
Lead Sponsor University of Valencia
Conditions Ocular Melanoma
Enrollment 40 participants
Start Date 2025-02-01
Primary Completion 2026-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2025-05-28